Nano-Sized Water-in-Oil-in-Water Emulsion with Lipopolysaccharide Enhancement Improves Immunogenicity and Accelerates the Decline of Viral Shedding in an Inactivated H5N1 (Clade 2.3.4.4b) Poultry Vaccine

Background/Objectives: Highly pathogenic avian influenza (HPAI) H5N1 clade 2.3.4.4b continues to spread globally, and conventional water-in-oil (W/O) emulsion-adjuvanted inactivated poultry vaccines show inconsistent immunogenicity. We evaluated whether reducing emulsion particle size and adding the Toll-like receptor 4 (TLR4) agonist lipopolysaccharide (LPS) improves the performance of an inactivated reassortant H5N1 (clade 2.3.4.4b) vaccine. Methods: Three formulations—a nano-sized water-in-oil-in-water (W/O/W) emulsion, an LPS-enhanced W/O/W emulsion, and a conventional W/O emulsion (Montanide ISA 71)—were characterized physicochemically and evaluated in specific-pathogen-free (SPF) chickens for hemagglutination-inhibition (HI) titers, IFN-γ and IL-6 expression, and protection after homologous challenge. Survival was compared by Kaplan–Meier analysis with the log-rank test, and viral shedding was assessed by RT-PCR and embryonated-egg passage. Results: The W/O/W emulsion was smaller (241 vs. 1095 nm) and less viscous than the conventional emulsion (both p < 0.001). LPS enhancement increased HI titers relative to the size-matched standard W/O/W formulation (7.3 vs. 7.0 log2; p < 0.01) and increased IFN-γ and IL-6 expression (p < 0.001). Both W/O/W formulations cleared detectable viral shedding by day 7, confirmed by egg passage, whereas the conventional group continued to shed virus (p < 0.001). Survival (95%, 90%, and 85%) did not differ significantly among vaccinated groups (log-rank p = 0.60). Conclusions: The nano-sized W/O/W formulation, with LPS adjuvantation, improved immunogenicity and accelerated viral clearance relative to the conventional emulsion, supporting further evaluation of nano-emulsion/LPS adjuvants for inactivated poultry influenza vaccines.

Authors

Institutions

Publication Details

Journal
Vaccines
Published
2026-11-12
DOI
https://doi.org/10.3390/vaccines14110974
Primary Topic
Influenza Virus Research Studies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Nano-Sized Water-in-Oil-in-Water Emulsion with Lipopolysaccharide Enhancement Improves Immunogenicity and Accelerates the Decline of Viral Shedding in an Inactivated H5N1 (Clade 2.3.4.4b) Poultry Vaccine

Dalia M. Omar, Sara Hussein Mahmoud, Owais J.A. Salman, Ahmed Khalil et al.
Vaccines
Influenza Virus Research Studies
article

Nano-Sized Water-in-Oil-in-Water Emulsion with Lipopolysaccharide Enhancement Improves Immunogenicity and Accelerates the Decline of Viral Shedding in an Inactivated H5N1 (Clade 2.3.4.4b) Poultry Vaccine

Dalia M. Omar, Sara Hussein Mahmoud, Owais J.A. Salman, Ahmed Khalil, Lamia M. Omer
article en

Abstract

Background/Objectives: Highly pathogenic avian influenza (HPAI) H5N1 clade 2.3.4.4b continues to spread globally, and conventional water-in-oil (W/O) emulsion-adjuvanted inactivated poultry vaccines show inconsistent immunogenicity. We evaluated whether reducing emulsion particle size and adding the Toll-like receptor 4 (TLR4) agonist lipopolysaccharide (LPS) improves the performance of an inactivated reassortant H5N1 (clade 2.3.4.4b) vaccine. Methods: Three formulations—a nano-sized water-in-oil-in-water (W/O/W) emulsion, an LPS-enhanced W/O/W emulsion, and a conventional W/O emulsion (Montanide ISA 71)—were characterized physicochemically and evaluated in specific-pathogen-free (SPF) chickens for hemagglutination-inhibition (HI) titers, IFN-γ and IL-6 expression, and protection after homologous challenge. Survival was compared by Kaplan–Meier analysis with the log-rank test, and viral shedding was assessed by RT-PCR and embryonated-egg passage. Results: The W/O/W emulsion was smaller (241 vs. 1095 nm) and less viscous than the conventional emulsion (both p < 0.001). LPS enhancement increased HI titers relative to the size-matched standard W/O/W formulation (7.3 vs. 7.0 log2; p < 0.01) and increased IFN-γ and IL-6 expression (p < 0.001). Both W/O/W formulations cleared detectable viral shedding by day 7, confirmed by egg passage, whereas the conventional group continued to shed virus (p < 0.001). Survival (95%, 90%, and 85%) did not differ significantly among vaccinated groups (log-rank p = 0.60). Conclusions: The nano-sized W/O/W formulation, with LPS adjuvantation, improved immunogenicity and accelerated viral clearance relative to the conventional emulsion, supporting further evaluation of nano-emulsion/LPS adjuvants for inactivated poultry influenza vaccines.

VaccinesVol. 14(11)
Veterinary Serum and Vaccine Research Institute (EG), National Research Centre (EG), Agricultural Research Center (EG)
Academy of Scientific Research and Technology
Good health and well-being
Influenza Virus Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon